Freeport-McMoRan Inc. (FCX) Bundle
Morgan Stanley Raises Freeport-McMoRan Price Target to $53
On December 15, 2025, Morgan Stanley maintained its Overweight rating for Freeport-McMoRan (NYSE:FCX) and increased its price target to $53 from $44. The revision indicates confidence in the future performance of the mining company, which specializes in copper and gold production.
Freeport-McMoRan (NYSE:FCX) shares were trading at $47.55 on December 18, 2025, marking a 0.4% increase. The stock experienced volatility throughout the session, reaching an intraday high of $48.85 and a low of $47.39. Over the past 12 months, the share price has ranged from $27.66 to $49.12.
The company is currently involved in a securities fraud lawsuit initiated by the Rosen Law Firm. Investors who purchased FCX securities between February 15, 2022, and September 24, 2025, have until January 12, 2026, to apply for the role of lead plaintiff in the class action. The legal challenge follows a period of significant operations across the company assets.
Freeport-McMoRan maintains a market capitalization of approximately $68.27 billion. Trading activity on December 18, 2025, reached 10.93 million shares, reflecting continued investor engagement. The firm operates extensive reserves of molybdenum alongside its primary copper and gold assets, competing with global entities such as BHP and Rio Tinto.
Market data and company profiles for Freeport-McMoRan are detailed in the following resources:
- Corporate background: FCX-history-mission-ownership
- Strategic objectives: FCX-mission-vision
- Fiscal analysis: FCX-financial-health
- Shareholder data: FCX-investor-profile
The company continues to hold a significant position in the mining sector despite the ongoing legal proceedings. The price target increase to $53 suggests potential growth as the firm manages its geographically diverse asset portfolio.
Freeport-McMoRan Inc. (FCX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.